Citigroup plans barrier notes linked to iShares Nasdaq Biotechnology

By Angela McDaniels

Tacoma, Wash., Dec. 2 – Citigroup Global Markets Holdings Inc. plans to price 0% barrier securities due Dec. 16, 2019 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by Citigroup Inc.

If the final share price is greater than or equal to the initial share price, the payout at maturity will be par plus 300% of the ETF return, subject to a maximum return that is expected to be 35% and will be set at pricing.

If the final share price is less than the initial share price but greater than or equal to the barrier level, 75% of the initial share price, the payout will be par.

If the final share price is less than the barrier level, investors will lose 1% for every 1% that the final share price is less than the initial share price.

Citigroup Global Markets Inc. is the agent.

The notes will price Dec. 8.

The Cusip number is 17324CDC7.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.